Glaxo withdraws charge against CIPLA.



      Glaxo has reported admitted its "mistake" of accusing CIPLA of violating its patent in Ghana by offering the generic version of an AIDS drug at lower prices , said Wall Street Journal.The cost of AIDS drugs sold by MNCs in Africa was between 10,000 to 15,000 dollars, while CIPLA charged 300 dollars, it said.